Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave in Deal with British Institutions

NEW YORK, Sept 14 - Third Wave Technologies said Thursday it had reached an agreement to provide Imperial College of Great Britain, Royal Brompton's Hospital, and the UK National Health Service Trust with access to its Invader operating system for SNP detection and gene expression analysis.

Under the terms of the deal, Third Wave of Madison, Wis., will provide the institutions with preferred access to its pharmacogenomic assays as well as offer additional support for their genomics research.

In exchange, Third Wave will receive exclusive rights to commercialize discoveries made under the agreement for research, diagnostic and therapeutic uses.

The agreement includes other terms and conditions designed to avoid interference with academic researchers' freedom to collaborate with others and publish scientific results.

"This is a key new initiative that offers us the potential to launch large-scale pharmacogenomic studies based on our large number of stratified patient DNA samples," Ron du Bois, of the respiratory medicine unit at Royal Brompton's Hospital, said in a statement.

"The effort will result in our ability to begin identifying a genetic basis for cardiac and pulmonary diseases."

Third Wave develops and provides DNA and RNA analysis technologies for use in genome research, pharmacogenomics, and clinical applications.

The company has agreements with some of the leading pharmaceutical companies and research centers in the United States and Great Britain.

The company recently filed for an initial public offering on the Nasdaq.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.